Zentalis Pharmaceuticals, Inc.
ZNTL
$1.43
-$0.08-5.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.16% | -24.27% | -22.89% | 24.58% | 10.41% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.66% | -22.44% | 20.91% | -16.29% | -5.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -22.28% | -24.23% | -22.04% | 22.81% | 9.91% |
|
|
|||||
| Total Current Assets | -22.28% | -24.23% | -22.04% | 22.81% | 9.91% |
| Net Property, Plant & Equipment | -10.80% | -9.77% | -10.23% | -8.91% | -16.66% |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.84% | -26.05% | -9.75% | -21.37% | -23.09% |
| Total Assets | -22.00% | -23.06% | -20.88% | 13.92% | 2.30% |
|
|
|||||
| Total Accounts Payable | -50.17% | -42.50% | 66.11% | -18.07% | 32.71% |
| Total Accrued Expenses | 69.78% | 3.52% | 16.16% | -0.34% | 20.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.12% | 15.84% | 16.02% | 21.90% | 21.32% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -26.82% |
| Total Other Current Liabilities | -- | -- | -- | -- | -26.82% |
| Total Current Liabilities | -23.99% | -6.86% | 28.85% | -2.77% | 22.45% |
|
|
|||||
| Total Current Liabilities | -23.99% | -6.86% | 28.85% | -2.77% | 22.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.28% | -6.49% | -6.15% | -4.81% | -4.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -52.30% | -39.05% | -54.17% | -49.22% | -48.75% |
| Total Liabilities | -18.50% | -7.21% | 11.14% | -4.79% | 8.56% |
|
|
|||||
| Common Stock & APIC | 5.09% | 3.81% | 4.14% | 27.82% | 28.32% |
| Retained Earnings | -18.66% | -21.66% | -25.21% | -33.19% | -49.00% |
| Treasury Stock & Other | -74.57% | 544.01% | 141.42% | 239.03% | 262.16% |
| Total Common Equity | -22.89% | -26.45% | -26.87% | 19.01% | 0.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.89% | -26.45% | -26.87% | 19.01% | 0.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -51.58% |
| Total Equity | -22.91% | -26.47% | -26.89% | 18.96% | 0.78% |
|
|
|||||